3-101326008-G-A
Variant summary
Our verdict is Likely pathogenic. The variant received 6 ACMG points: 6P and 0B. PM2PP3_ModeratePP5_Moderate
The NM_020654.5(SENP7):c.3088C>T(p.Arg1030Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000658 in 151,934 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Consequence
NM_020654.5 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 6 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151934Hom.: 0 Cov.: 32 show subpopulations
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1458648Hom.: 0 Cov.: 30 AF XY: 0.00 AC XY: 0AN XY: 725596
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151934Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74192 show subpopulations
ClinVar
Submissions by phenotype
Arthrogryposis Multiplex Congenita and Immunodeficiency Pathogenic:1
Biallelic loss-of-function variations in the SENP7 gene have been reported in literature to cause fatal arthrogryposis multiplex congenita, early respiratory failure and neutropenia [PMID:37460201]. The c.3088C>T was observed in a fetal sample with symptoms of arthrogryposis. This variant is not present in publicly available population databases like 1000 Genomes, EVS, ExAC, gnomAD, Indian Exome Database or our in-house exome database. This variant has neither been published in literature with SENP7-related conditions nor reported to the clinical databases like ClinVar, Human Genome Mutation Database (HGMD) or OMIM, in any affected individuals. In-silico pathogenicity prediction programs like SIFT, PolyPhen-2, MutationTaster2021, CADD etc predicted this variant to be likely deleterious, however these predictions were not confirmed by published functional studies. Our internal in-silico analysis suggest a deleterious effect of this variant on protein structure and function, however further experimental evidence is required to prove this. By considering PM2 (moderate), PP3 (moderate), PM1 (supporting) and PP4 (supporting) criteria of the ACMG guidelines, we classified this variant as likely pathogenic [Pal et al. Clinical Genetics, 2025]. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at